May 15, 2024
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
April 18, 2024
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
February 14, 2024
Jardiance® (empagliflozin) now approved in India for the treatment of adults with chronic kidney disease
February 01, 2024
Boehringer Ingelheim India earns ‘‘Top Employer 2024’’ accolade for second consecutive year
September 20, 2023
Boehringer Ingelheim India joins forces with Pet Practitioners Association of Mumbai (PPAM) and Brihanmumbai Municipal Corporation (BMC) to ‘Stop Rabies’ in Mumbai
August 10, 2023
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
June 26, 2023
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
June 20, 2023
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
March 27, 2023
Boehringer Ingelheim India joins hands with Startup Incubation and Innovation Centre (SIIC), IIT Kanpur to support socially impactful innovations
June 06, 2022
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
November 25, 2021
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™
Media Contacts
Director, Communications, Boehringer Ingelheim India
Senior Manager, Communications, Boehringer Ingelheim India